Company overview
Basic information
Company name
Mikronika, MB
Company code
306265492
VAT code
LT100015850214
Registered address
Vilnius, Giedraičių g. 39-R53, LT-09302
Registration date
2023-03-06
Company age: 3 y. 6 mo.
Contact information
Edit data
Phone
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Website
https://mikronika.eu
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
Retail sale of pharmaceutical products
Ownership form
Private without foreign capital
Mikronika MB
Company code: 306265492
Address: Vilnius, Giedraičių g. 39-R53, LT-09302
VAT code: LT100015850214
Download a detailed company report
Make confident decisions with all the information about Mikronika, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.
Description
This description was generated by artificial intelligence.
Mikronika, MB (company code 306265492) is an operational private small partnership registered in 2023. It belongs to the sector of national private non-financial companies and is owned under private ownership, with Lithuanian natural and legal persons holding more than 50% of the authorised capital and no foreign investor capital. The governance structure is listed as CEO only. The company is classified as micro in size and operates from Vilnius, Giedraiciu g. 39-R53, in Vilniaus m. municipality, Vilniaus county.
Its main activity is EVRK code G.47.73.00, Retail sale of pharmaceutical products. Financially, the company moved from very small turnover and losses in 2023 and 2024 to a clearer positive result in 2025. Revenue increased from €274 in 2023 to €3.7K in 2024 and €21.7K in 2025. Net profit was negative in 2023 and 2024, then rose to €4.1K in 2025, with a 19.1% profit margin. At the end of 2025, equity stood at €3.2K, total assets at €8.0K, and liabilities at €5.0K.
Its main activity is EVRK code G.47.73.00, Retail sale of pharmaceutical products. Financially, the company moved from very small turnover and losses in 2023 and 2024 to a clearer positive result in 2025. Revenue increased from €274 in 2023 to €3.7K in 2024 and €21.7K in 2025. Net profit was negative in 2023 and 2024, then rose to €4.1K in 2025, with a 19.1% profit margin. At the end of 2025, equity stood at €3.2K, total assets at €8.0K, and liabilities at €5.0K.